Christopher Yea Kal Vista Pharmaceuticals, Inc. (KALV) insider trading activity
Christopher Yea is CHIEF DEVELOPMENT OFFICER of KalVista Pharmaceuticals, Inc.. Currently has a direct ownership of 85,676 shares of KALV, which is worth approximately $1.06 Million. The most recent transaction as insider was on Aug 23, 2024, when has been sold 1,916 shares (Common Stock) at a price of $12.4 per share, resulting in proceeds of $23,758. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
85.7K
7.0%
3M change
105.65%
12M change
Total Value Held
$1.06 Million
Christopher Yea Transaction History
CY
Christopher Yea
CHIEF DEVELOPMENT OFFICER
Cambridge, MA